Company profile

Xilio Therapeutics, Inc. Insider Trading

XLO

Every SEC Form 4 insider trading filing for Xilio Therapeutics, Inc. (XLO) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
CIK
0001840233
Filings
73
Insiders
23
Last filing
2026-06-11

Activity summary

No insider transactions in the last 30 days. The most recent was on June 11, 2026, when Bonstein Sara bought 5,000 shares. 73 filings from 23 insiders are on record below.

Three year balance

Buy and sell value by quarter, Q2 23 to Q2 26. Xilio Therapeutics, Inc. insiders are net buyers across the period shown.

Q2 23Q3 23Q1 24Q2 24Q3 24Q4 24Q1 25Q2 25Q4 25Q1 26Q2 26

Bars below the rule are sales, above are purchases. Largest quarter on the chart is $8.2M.

90 day insight

Over the last 90 days, Xilio Therapeutics, Inc. insiders bought $0 across 7 transactions with no open-market sales.

  • Most active insider: Bonstein Sara with 1 transaction totaling $0.

Activity skews bullish — buys outpace sales.

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 11, 2026Bonstein SaraXLO
Award
5,000
Jun 11, 2026Brennan AoifeXLO
Award
5,000
Jun 11, 2026Xu YuanXLO
Award
5,000
Jun 11, 2026Ross Robert W.XLO
Award
5,000
Jun 11, 2026Shannon James SamuelXLO
Award
5,000

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Query this yourself

The same rows, over the API.

curl "https://api.form4api.com/v1/transactions?ticker=XLO" \
  -H "X-Api-Key: $KEY"
Get a key

Top insiders

By total value filed.

Gilead Sciences, Inc.10% owner1 filing+$2.0M
Frankenfield Christopher JamesCHIEF OPERATING OFFICER1 filing$5K
Brennan Kevin M.SVP, FINANCE AND ACCOUNTING1 filing$1K

Institutional Ownership

Top 13F-HR holders of Xilio Therapeutics, Inc. as of 2026-06-30

— stable
Total reported AUM
$1.2M
QoQ change
Reporting period
2026-06-30
#1
Merck & Co., Inc.
CIK 0000310158
$1.0M
106K shares
#2
State Street Corp
CIK 0000093751
$127,519
13K shares
#3
BlackRock, Inc.
CIK 0002012383
$78,738
8K shares

Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →